Jean-Philippe Pignol
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Jean-Philippe Pignol has a total of 670 co-authors. Here are the top co-authors by number of shared publications:
E. Rakovitch
Univ Toronto, Sunnybrook Odette Canc Ctr, Radiat Oncol, Toronto, ON, Canada
16 shared publications- Zhongli Cai
Department of Pharmaceutical Sciences, University of Toronto, Toronto, ON, Canada
12 shared publications - Brigitte Reniers
Research group NuTeC, Centre for Environmental Sciences, Hasselt University, Diepenbeek, Belgium
10 shared publications Eli Lechtman
University of Toronto
10 shared publicationsEileen Rakovitch
Sunnybrook Health Sciences Centre, Institute for Clinical Evaluative Sciences and Radiation Oncology Department, Toronto, Canada
9 shared publications- Raymond M. Reilly
Department of Pharmaceutical Sciences, Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Canada
9 shared publications
Latest Publications
- 16 June 2026
- Published by Elsevier in Physica Medica
- Vol. 148, 105861
Skin dose in post-mastectomy radiotherapy – a comparative analysis of field-in-field intensity modulated radiotherapy and volumetric modulated arc therapy
- 16 June 2026
- Published by Elsevier in Physica Medica
- Vol. 148, 105861
Skin dose in post-mastectomy radiotherapy – a comparative analysis of field-in-field intensity modulated radiotherapy and volumetric modulated arc therapy
- Open Access
- 19 May 2026
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 221, 111607
Artificial intelligence classification of spatial CD8 + T-cell distribution on computed tomography in oropharyngeal cancer
- 19 May 2026
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 221, 111607
Open AccessArtificial intelligence classification of spatial CD8 + T-cell distribution on computed tomography in oropharyngeal cancer
- 27 January 2025
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 205, 110749
Stabilised hyaluronic acid gel marker versus surgical clips for tumour bed delineation in breast cancer radiotherapy using MRI-simulation
- 27 January 2025
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 205, 110749
Stabilised hyaluronic acid gel marker versus surgical clips for tumour bed delineation in breast cancer radiotherapy using MRI-simulation
- 8 August 2024
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 199, 110471
Deep Inspiration breath Hold facilitates surgical cavity registration on cone beam imaging for Partial breast irradiation
- 8 August 2024
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 199, 110471
Deep Inspiration breath Hold facilitates surgical cavity registration on cone beam imaging for Partial breast irradiation
- Open Access
- 18 October 2022
- Published by MDPI AG in Nanomaterials
- Vol. 12 (20) , 3649
From Structure to Function: Understanding Synthetic Conditions in Relation to Magnetic Properties of Hybrid Pd/Fe-Oxide Nanoparticles
Heterostructured magnetic nanoparticles show great potential for numerous applications in biomedicine due to their ability to express multiple functionalities in a single structure. Magnetic properties are generally determined by the morphological characteristics of nanoparticles, such as the size/shape, and composition of the nanocrystals. These in turn are highly dependent on the synthetic conditions applied. Additionally, incorporation of a non-magnetic heterometal influences the final magnetic behavior. Therefore, construction of multifunctional hybrid nanoparticles with preserved magnetic properties represents a certain nanotechnological challenge. Here, we focus on palladium/iron oxide nanoparticles designed for combined brachytherapy, the internal form of radiotherapy, and MRI-guided hyperthermia of tumors. The choice of palladium forming the nanoparticle core is envisioned for the eventual radiolabeling with 103Pd to enable the combination of hyperthermia with brachytherapy, the latter being beyond the scope of the present study. At this stage, we investigated the synthetic mechanisms and their effects on the final magnetic properties of the hybrid nanoparticles. Thermal decomposition was applied for the synthesis of Pd/Fe-oxide nanoparticles via both, one-pot and seed-mediated processes. The latter method was found to provide better control over morphology of the nanoparticles and was therefore examined closely by varying reaction conditions. This resulted in several batches of Pd/Fe-oxide nanoparticles, whose magnetic properties were evaluated, revealing the most relevant synthetic parameters leading to promising performance in hyperthermia and MRI.
- 18 October 2022
- Published by MDPI AG in Nanomaterials
- Vol. 12 (20) , 3649
Open AccessFrom Structure to Function: Understanding Synthetic Conditions in Relation to Magnetic Properties of Hybrid Pd/Fe-Oxide Nanoparticles
Heterostructured magnetic nanoparticles show great potential for numerous applications in biomedicine due to their ability to express multiple functionalities in a single structure. Magnetic properties are generally determined by the morphological characteristics of nanoparticles, such as the size/shape, and composition of the nanocrystals. These in turn are highly dependent on the synthetic conditions applied. Additionally, incorporation of a non-magnetic heterometal influences the final magnetic behavior. Therefore, construction of multifunctional hybrid nanoparticles with preserved magnetic properties represents a certain nanotechnological challenge. Here, we focus on palladium/iron oxide nanoparticles designed for combined brachytherapy, the internal form of radiotherapy, and MRI-guided hyperthermia of tumors. The choice of palladium forming the nanoparticle core is envisioned for the eventual radiolabeling with 103Pd to enable the combination of hyperthermia with brachytherapy, the latter being beyond the scope of the present study. At this stage, we investigated the synthetic mechanisms and their effects on the final magnetic properties of the hybrid nanoparticles. Thermal decomposition was applied for the synthesis of Pd/Fe-oxide nanoparticles via both, one-pot and seed-mediated processes. The latter method was found to provide better control over morphology of the nanoparticles and was therefore examined closely by varying reaction conditions. This resulted in several batches of Pd/Fe-oxide nanoparticles, whose magnetic properties were evaluated, revealing the most relevant synthetic parameters leading to promising performance in hyperthermia and MRI.
- Open Access
- 17 February 2022
- Published by Elsevier in Physics and Imaging in Radiation Oncology
- Vol. 21, 48-53
Comparison of visibility of iodinated hydrogel and gadolinium-modified hyaluronic acid spacer gels on computed tomography and onboard imaging
- 17 February 2022
- Published by Elsevier in Physics and Imaging in Radiation Oncology
- Vol. 21, 48-53
Open AccessComparison of visibility of iodinated hydrogel and gadolinium-modified hyaluronic acid spacer gels on computed tomography and onboard imaging
- Open Access
- 9 August 2021
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 11, 713328
Estimation of Annual Secondary Lung Cancer Deaths Using Various Adjuvant Breast Radiotherapy Techniques for Early-Stage Cancers
Purpose: Secondary lung cancer (SLC) can offset the benefit of adjuvant breast radiotherapy (RT), and risks compound sharply after 25 to 30 years. We hypothesized that SLC risk is mainly an issue for early-stage breast cancer, and that lives could be saved using different RT techniques.Patients and Methods: The SEER database was used to extract breast patient age, stage survival, and radiotherapy utilization over time and per stage and to assess the factors associated with increased SLC risk with a multivariable competing risk Cox model. The number of SLC was calculated using the BEIR model modified with patient survival, age, and use of RT from the SEER database. Stage distribution and number of new breast cancer cases were obtained from the NAACCR. Mean lung dose for various irradiation techniques was obtained from measurement or literature.Results: Out of the 765,697 non-metastatic breast cancers in the SEER database from 1988 to 2012, 49.8% received RT. RT significantly increased the SLC risk for longer follow-up (HR=1.58), early stage including DCIS, stage I and IIA (HR = 1.11), and younger age (HR=1.061) (all p<0.001). More advanced stages did not have significantly increased risk. In 2019, 104,743 early-stage breast patients received radiotherapy, and an estimated 3,413 will develop SLC (3.25%) leading to an excess of 2,900 deaths (2.77%). VMAT would reduce this mortality by 9.9%, hypofractionation 26 Gy in five fractions by 38.8%, a prone technique by 70.3%, 3D-CRT APBI by 43.3%, HDR brachytherapy by 71.1%, LDR by 80.7%, and robotic 4π APBI by 85.2%.Conclusions: SLC after breast RT remains a clinically significant issue for early-stage breast cancers. This mortality could be significantly reduced using a prone technique or APBI.
- 9 August 2021
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 11, 713328
Open AccessEstimation of Annual Secondary Lung Cancer Deaths Using Various Adjuvant Breast Radiotherapy Techniques for Early-Stage Cancers
Purpose: Secondary lung cancer (SLC) can offset the benefit of adjuvant breast radiotherapy (RT), and risks compound sharply after 25 to 30 years. We hypothesized that SLC risk is mainly an issue for early-stage breast cancer, and that lives could be saved using different RT techniques.Patients and Methods: The SEER database was used to extract breast patient age, stage survival, and radiotherapy utilization over time and per stage and to assess the factors associated with increased SLC risk with a multivariable competing risk Cox model. The number of SLC was calculated using the BEIR model modified with patient survival, age, and use of RT from the SEER database. Stage distribution and number of new breast cancer cases were obtained from the NAACCR. Mean lung dose for various irradiation techniques was obtained from measurement or literature.Results: Out of the 765,697 non-metastatic breast cancers in the SEER database from 1988 to 2012, 49.8% received RT. RT significantly increased the SLC risk for longer follow-up (HR=1.58), early stage including DCIS, stage I and IIA (HR = 1.11), and younger age (HR=1.061) (all p<0.001). More advanced stages did not have significantly increased risk. In 2019, 104,743 early-stage breast patients received radiotherapy, and an estimated 3,413 will develop SLC (3.25%) leading to an excess of 2,900 deaths (2.77%). VMAT would reduce this mortality by 9.9%, hypofractionation 26 Gy in five fractions by 38.8%, a prone technique by 70.3%, 3D-CRT APBI by 43.3%, HDR brachytherapy by 71.1%, LDR by 80.7%, and robotic 4π APBI by 85.2%.Conclusions: SLC after breast RT remains a clinically significant issue for early-stage breast cancers. This mortality could be significantly reduced using a prone technique or APBI.
- Top Cited Papers
- 22 December 2020
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 298 (2) , 248-260
MRI-guided Radiation Therapy: An Emerging Paradigm in Adaptive Radiation Oncology
The integration of MRI and linear accelerators is revolutionizing cancer treatments, offering possibilities to adapt radiation therapy with greater precision and in real time to account for anatomi... Radiation therapy (RT) continues to be one of the mainstays of cancer treatment. Considerable efforts have been recently devoted to integrating MRI into clinical RT planning and monitoring. This in...
- 22 December 2020
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 298 (2) , 248-260
Top Cited PapersMRI-guided Radiation Therapy: An Emerging Paradigm in Adaptive Radiation Oncology
The integration of MRI and linear accelerators is revolutionizing cancer treatments, offering possibilities to adapt radiation therapy with greater precision and in real time to account for anatomi... Radiation therapy (RT) continues to be one of the mainstays of cancer treatment. Considerable efforts have been recently devoted to integrating MRI into clinical RT planning and monitoring. This in...
- 1 October 2020
- Published by Elsevier in European Journal of Cancer
- Vol. 138, S6
The risk of cardiovascular disease in irradiated breast cancer patients: The role of cardiac calcifications and adjuvant treatment
- 1 October 2020
- Published by Elsevier in European Journal of Cancer
- Vol. 138, S6
The risk of cardiovascular disease in irradiated breast cancer patients: The role of cardiac calcifications and adjuvant treatment
- 1 January 2020
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 142, 261
Response to Comment on - Long-term risks of secondary cancers for various whole and partial breast irradiation techniques
- 1 January 2020
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 142, 261
Response to Comment on - Long-term risks of secondary cancers for various whole and partial breast irradiation techniques